Literature DB >> 28984120

Summary of global update on preventive chemotherapy implementation in 2016: crossing the billion.

.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28984120

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  25 in total

1.  Interactions of Caenorhabditis elegans β-tubulins with the microtubule inhibitor and anthelmintic drug albendazole.

Authors:  Linda M Pallotto; Clayton M Dilks; Ye-Jean Park; Ryan B Smit; Brian T Lu; Chandrasekhar Gopalakrishnan; John S Gilleard; Erik C Andersen; Paul E Mains
Journal:  Genetics       Date:  2022-07-30       Impact factor: 4.402

2.  "Rapid impact" 10 years after: The first "decade" (2006-2016) of integrated neglected tropical disease control.

Authors:  Peter J Hotez; Alan Fenwick; Sarah E Ray; Simon I Hay; David H Molyneux
Journal:  PLoS Negl Trop Dis       Date:  2018-05-24

Review 3.  The control of soil-transmitted helminthiases in the Philippines: the story continues.

Authors:  Donald P McManus; Darren J Gray; Mary Lorraine S Mationg; Veronica L Tallo; Gail M Williams; Catherine A Gordon; Archie C A Clements
Journal:  Infect Dis Poverty       Date:  2021-06-12       Impact factor: 10.485

4.  Population Pharmacokinetics of Diethylcarbamazine in Patients with Lymphatic Filariasis and Healthy Individuals.

Authors:  Veenu Bala; Yashpal S Chhonker; Abdullah Alshehri; Constant Edi; Catherine M Bjerum; Benjamin G Koudou; Christopher L King; Daryl J Murry
Journal:  Antimicrob Agents Chemother       Date:  2021-07-26       Impact factor: 5.938

5.  In Southern Nigeria Loa loa Blood Microfilaria Density is Very Low Even in Areas with High Prevalence of Loiasis: Results of a Survey Using the New LoaScope Technology.

Authors:  Emmanuel Emukah; Lindsay J Rakers; Barminas Kahansim; Emmanuel S Miri; Bertram E B Nwoke; Emily Griswold; Yisa Saka; Ifeoma Anagbogu; Emmanuel Davies; Cephas Ityonzughul; Michael D'Ambrosio; Matthew Bakalar; Daniel A Fletcher; Thomas Nutman; Joseph Kamgno; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2018-05-10       Impact factor: 3.707

6.  Understanding heterogeneities in mosquito-bite exposure and infection distributions for the elimination of lymphatic filariasis.

Authors:  Michael A Irvine; James W Kazura; T Deirdre Hollingsworth; Lisa J Reimer
Journal:  Proc Biol Sci       Date:  2018-01-31       Impact factor: 5.530

7.  Ensuring no one is left behind: Urgent action required to address implementation challenges for NTD control and elimination.

Authors:  Alison Krentel; Margaret Gyapong; Olumide Ogundahunsi; Mary Amuyunzu-Nyamongo; Deborah A McFarland
Journal:  PLoS Negl Trop Dis       Date:  2018-06-07

Review 8.  Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.

Authors:  Philip J Budge; Carly Herbert; Britt J Andersen; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2018-05-16

Review 9.  The History of Bancroftian Lymphatic Filariasis in Australasia and Oceania: Is There a Threat of Re-Occurrence in Mainland Australia?

Authors:  Catherine A Gordon; Malcolm K Jones; Donald P McManus
Journal:  Trop Med Infect Dis       Date:  2018-06-04

10.  Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.

Authors:  Christine L Dubray; Anita D Sircar; Valery Madsen Beau de Rochars; Joshua Bogus; Abdel N Direny; Jean Romuald Ernest; Carl R Fayette; Charles W Goss; Marisa Hast; Kobie O'Brian; Guy Emmanuel Pavilus; Daniel Frantz Sabin; Ryan E Wiegand; Gary J Weil; Jean Frantz Lemoine
Journal:  PLoS Negl Trop Dis       Date:  2020-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.